Recital 7, Regulation (EU) 2018/613

In forcesince 20 Apr 2018cited 3×

The opinions conclude that PHMB (1415; 4.7) meets the criteria for being a very persistent (vP) and toxic (T) substance in accordance with Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).]. PHMB (1415; 4.7) therefore meets the conditions set out in point (d) of Article 10(1) of Regulation (EU) No 528/2012 and should be considered a candidate for substitution.

  • Judgment of the General Court (Seventh Chamber) of 15 September 2021. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision

    Also on 20 April 2018, the Commission adopted Implementing Regulation (EU) 2018/613 approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 2 and 4 (OJ 2018 L 102, p. 1) (‘the contested …

    15 Sep 2021 · 62018TJ0337

  • Order of the President of the General Court of 24 August 2018. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision

    According to recitals 4 and 7 of the contested regulation, the opinions of the ECHA, as formulated on 4 October 2017 by the Biocidal Products Committee, concluded that PHMB (1415; 4.7) meets the criteria for being a very persistent (vP) …

    24 Aug 2018 · 62018TO0337

  • Judgment of the Court (Eighth Chamber) of 10 November 2022. Laboratoire Pareva v European Commission.Decision

    On the same day, the Commission adopted the regulation at issue. As is apparent from recital 5 of that regulation, the Commission considered that biocidal products of product-types 2 and 4 could be expected to satisfy the requirements of …

    10 Nov 2022 · 62021CJ0702